Abstract
The study was designed to investigate whether H2S could upregulate expression of KATP channels in vascular smooth muscle cells (VSMCs), and by this mechanism enhances vasorelaxation in spontaneously hypertensive rats (SHR). Blood pressure, vascular structure, and vasorelaxation were analyzed. Plasma H2S was detected using polarographic sensor. SUR2B and Kir6.1 expressions were detected in VSMCs of SHR and in A7r5 cells as well as primarily cultured ASMCs using real-time PCR, western blot, immunofluorescence, and confocal imaging. Nuclear translocation of forkhead transcription factors FOXO1 and FOXO3a in ASMCs was detected using laser confocal microscopy, and their binding activity with SUR2B and Kir6.1 promoters was examined by chromatin immunoprecipitation. SHR developed hypertension at 18 weeks. They showed downregulated vascular SUR2B and Kir6.1 expressions in association with a decreased plasma H2S level. H2S donor, however, could upregulate vascular SUR2B and Kir6.1 expressions, causing a left shift of the vasorelaxation curve to pinacidil and lowered tail artery pressure in the SHR. Also, H2S antagonized endothelin-1 (ET-1)-inhibited KATP expression in A7r5 cells and cultured ASMCs. Mechanistically, H2S inhibited ET-1-stimulated p-FOXO1 and p-FOXO3a expressions (inactivated forms), but increased their nuclear translocation and the ET-1-inhibited binding of FOXO1 and FOXO3a with Kir6.1 and SUR2B promoters in ASMCs. Hence, H2S promotes vasorelaxation of SHR, at least in part, through upregulating the expression of KATP subunits by inhibiting phosphorylation of FOXO1 and FOXO3a, and stimulating FOXO1 and FOXO3a nuclear translocation and their binding activity with SUR2B and Kir6.1 promoters.
Key messages
-
H2S increased vascular SUR2B and Kir6.1 expression of SHR, promoting vasorelaxation.
-
H2S antagonized ET-1-inhibited KATP expression in A7r5 cells and cultured ASMCs.
-
H2S inhibited ET-1-induced FOXO1 and FOXO3a phosphorylation in ASMCs.
-
H2S promoted FOXO1 and FOXO3a nuclear translocation and binding with target gene promoters.
Similar content being viewed by others
Change history
15 January 2021
A Correction to this paper has been published: https://doi.org/10.1007/s00109-021-02038-6
References
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747–1757
Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A et al (2009) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 27:2121–2158
Raj M, Krishnakumar R (2013) Hypertension in children and adolescents: epidemiology and pathogenesis. Indian J Pediatr 80:S71–S76
Hart JL (2011) Role of sulfur-containing gaseous substances in the cardiovascular system. Front Biosci (Elite Ed) 3:736–749
Zoccali C, Catalano C, Rastelli S (2009) Blood pressure control: hydrogen sulfide, a new gasotransmitter, takes stage. Nephrol Dial Transplant 24:1394–1396
Kabil O, Banerjee R (2010) Redox biochemistry of hydrogen sulfide. J Biol Chem 285:21903–21907
Shibuya N, Mikami Y, Kimura Y, Nagahara N, Kimura H (2009) Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem 146:623–626
Alexander SP, Mathie A, Peters JA (2008) Guide to receptors and channels (GRAC), 3rd edition. Br J Pharmacol 153(Suppl 2):S1–S209
Yan H, Du J, Tang C (2004) The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 313:22–27
Łowicka E, Bełtowski J (2007) Hydrogen sulfide (H2S)—the third gas of interest for pharmacologists. Pharmacol Rep 59:4–24
Prabha M, Jin HF, Tian Y, Tang CS, Du JB (2008) Mechanisms responsible for pulmonary hypertension. Chin Med J 121:2604–2609
Szabó C (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6:917–935
Tang C, Li XH, Du JB (2006) Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system. Curr Vasc Pharmacol 4:17–22
Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S et al (2008) H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322:587–590
Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM (2001) Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 88:2–11
Zhu P, Huang L, Ge X, Yan F, Wu R, Ao Q (2006) Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling. Int J Exp Pathol 87:463–474
Mustafa AK, Sikka G, Gazi SK, Steppan J, Jung SM, Bhunia AK, Barodka VM, Gazi FK, Barrow RK, Wang R et al (2011) Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res 109:1259–1268
Noma A (1983) ATP-regulated K+ channels in cardiac muscle. Nature 305:147–148
Quayle JM, Nelson MT, Standen NB (1997) ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 77:1165
Yang Y, Shi Y, Guo S, Zhang S, Cui N, Shi W, Zhu D, Jiang C (2008) PKA-dependent activation of the vascular smooth muscle isoform of KATP channels by vasoactive intestinal polypeptide and its effect on relaxation of the mesenteric resistance artery. Biochim Biophys Acta 1778:88–96
Mannhold R (2004) KATP channel openers: structure-activity relationships and therapeutic potential. Med Res Rev 24:213–266
Jin HF, Du JB, Tang CS (2010) “Waste gas is not waste”: advance in the research of hydrogen sulfide. Acta Physiol Sin 62:495–504
Kajimura M, Fukuda R, Bateman RM, Yamamoto T, Suematsu M (2010) Intractions of multiple gas-transducing systems: hallmarks and uncertainties of CO, NO, and H2S gas biology. Antioxid Redox Signal 13:157–192
Miller TW, Isenberg JS, Roberts DD (2009) Molecular regulation of tumor angiogenesis and perfusion via redox signaling. Chem Rev 109:3099–3124
Walford G, Loscalzo J (2003) Nitric oxide in vascular biology. J Thromb Haemost 1:2112–2118
Skovgaard N, Gouliaev A, Aalling M, Simonsen U (2011) The role of endogenous H2S in cardiovascular physiology. Curr Pharm Biotechnol 12:1385–1393
Hosoki R, Matsuki N, Kimura H (1997) The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237:527–531
Zhao W, Zhang J, Lu Y, Wang R (2001) The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 20:6008–6016
Fujita A, Kurachi Y (2000) Molecular aspects of ATP-sensitive K+ channels in the cardiovascular system and K+ channel openers. Pharmacol Ther 85:39–53
Lu C, Halvorsen SW (1997) Channel activators regulate ATP-sensitive potassium channel (kir6.1) expression in chick cardiomyocytes. FEBS Lett 412:121–125
Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H, Seino S (2002) Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med 8:466–472
Blanco-Rivero J, Gamallo C, Aras-López R, Cobeño L, Cogolludo A, Pérez-Vizcaino F, Ferrer M, Balfagon G (2008) Decreased expression of aortic KIR6.1 and SUR2B in hypertension does not correlate with changes in the functional role of K(ATP) channels. Eur J Pharmacol 587:204–208
Philip-Couderc P, Tavares NI, Roatti A, Lerch R, Montessuit C, Baertschi AJ (2008) Forkhead transcription factors coordinate expression of myocardial KATP channel subunits and energy metabolism. Circ Res 102:e20–e35
Whitfield NL, Kreimier EL, Verdial FC, Skovgaard N, Olson KR (2008) Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol 294:R1930–R1937
Xie L, Tiong CX, Bian JS (2012) Hydrogen sulfide protects SH-SY5Y cells against 6-hydroxydopamine-induced endoplasmic reticulum stress. Am J Physiol Cell Physiol 303:C81–C91
Zhao W, Wang R (2002) H2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 283:474–480
Ingenbleek Y, Kimura H (2013) Nutritional essentiality of sulfur in health and disease. Nutr Rev 71:413–432
Kimura H (2014) Production and physiological effects of hydrogen sulfide. Antioxid Redox Signal 20:783–793
Lohmeier TE (2002) Neurohumoral regulation of arterial pressure in hemorrhage and heart failure. Am J Physiol Regul Integr Comp Physiol 283:R810–R814
Bełtowski J (2010) Hypoxia in the renal medulla: implications for hydrogen sulfide signaling. J Pharmacol Exp Ther 334:358–363
Liew HC, Khoo HE, Moore PK, Bhatia M, Lu J, Moochhala SM (2007) Synergism between hydrogen sulfide (H2S) and nitric oxide (NO) in vasorelaxation induced by stonustoxin (SNTX), a lethal and hypotensive protein factor isolated from atonefish synanceia horrida venom. Life Sci 80:1664–1668
Lee SW, Cheng Y, Moore PK, Bian JS (2007) Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells. Biochem Biophys Res Commun 358:1142–1147
Weimin Z, Jing Z, Yanjie L, Rui W (2001) The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 20:6008–6016
Schreier B, Rabe S, Schneider B, Bretschneider M, Rupp S, Ruhs S, Neumann J, Rueckschloss U, Sibilia M, Gotthardt M et al (2013) Loss of epidermal growth factor receptor in vascular smooth muscle cells and cardiomyocytes causes arterial hypotension and cardiac hypertrophy. Hypertension 61:333–340
Zhang Y, Guan Y, Schneider A, Brandon S, Breyer RM, Breyer MD (2000) Characterization of murine vasopressor and vasodepressor prostaglandin E(2) receptors. Hypertension 35:1129–1134
Butz GM, Davisson RL (2001) Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics 5:89–97
Yamamoto K, Sokabe T, Matsumoto T, Yoshimura K, Shibata M, Ohura N, Fukuda T, Sato T, Sekine K, Kato S et al (2006) Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med 12:133–137
Acknowledgments
This work was supported by Major Basic Research Development Program of People's Republic of China (2012CB517806, 2013CB933801), National Natural Science Foundation of China (81100181 and 81121061), Beijing Natural Science Foundation (7121014, 7122184), Grant of Ministry of Education, China (20130001120047) and Program for New Century Excellent Talents of Ministry of Education, China (NCET-11-0005).
Conflict of interest
The authors have no financial conflict to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
Yan Sun, Yaqian Huang, and Rongyuan Zhang contributed equally to this work
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 91 kb)
Rights and permissions
About this article
Cite this article
Sun, Y., Huang, Y., Zhang, R. et al. Hydrogen sulfide upregulates KATP channel expression in vascular smooth muscle cells of spontaneously hypertensive rats. J Mol Med 93, 439–455 (2015). https://doi.org/10.1007/s00109-014-1227-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-014-1227-1